Glucagon and the a Cell
- 18 June 1981
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 304 (25) , 1518-1524
- https://doi.org/10.1056/nejm198106183042504
Abstract
IN this review we examine the role of glucagon, a polypeptide produced by the islets of Langerhans and a biologic antagonist of insulin. The effects of glucagon balance those of insulin so that fluctuations in blood sugar levels in response to sudden changes in fluxes of fuels are prevented.By definition, relative hyperglucagonemia is present in all forms of diabetes in which glucose production exceeds glucose disposal and thus causes "endogenous hyperglycemia"; in the absence of glucagon-like biologic activity the massive hepatic overproduction of glucose and ketones observed in uncontrolled diabetes does not occur, even in the total absence of . . .Keywords
This publication has 45 references indexed in Scilit:
- Binding, internalization, and lysosomal association of 125I-glucagon in isolated rat hepatocytes. A quantitative electron microscope autoradiographic study.Journal of Clinical Investigation, 1980
- Glucagon and glicentin immunoreactivity are topologically segregated in the α granule of the human pancreatic A cellNature, 1980
- Identification and processing of proglucagon in pancreatic isletsNature, 1979
- Glucagon and diabetes: A reappraisalDiabetologia, 1979
- Glucose Disposal during Insulinopenia in Somatostatin-Treated DogsJournal of Clinical Investigation, 1978
- FUNCTIONAL SUBDIVISION OF ISLETS OF LANGERHANS AND POSSIBLE ROLE OF D CELLSThe Lancet, 1975
- PLasma glucagon levels during rapid exsanguination with and without adrenergic blockadeDiabetes, 1975
- Structural coupling between pancreatic islet cellsCellular and Molecular Life Sciences, 1973
- IMMUNOCHEMICAL GLUCAGON IN HUMAN PANCREAS, GUT, AND PLASMAThe Lancet, 1966
- The effect of epinephrine on immunoreactive insulin levels in man.Journal of Clinical Investigation, 1966